ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2022
Phase-Transition-Cycle-Induced Recrystallization of FAPbI3 Film in An Open Environment Toward Excellent Photodetectors with High Reproducibility.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Phase-Transition-Cycle-Induced Recrystallization of FAPbI3 Film in An Open Environment Toward Excellent Photodetectors with High Reproducibility.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Perovskite is an attractive building block for future optoelectronic applications. However, the strict fabrication conditions of perovskite devices impede the transformation of lab techniques into commercial applications. Here, a facile annealing-free posttreatment is proposed to reconstruct the perovskite film to obtain high-performance photodetectors with an optimized production rate. With posttreatment by methylamine thiocyanate, the prefabricated formamidinium-lead triiodide (FAPbI
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.